Filing Details
- Accession Number:
- 0001179110-16-022971
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-12 16:54:24
- Reporting Period:
- 2016-04-11
- Filing Date:
- 2016-04-12
- Accepted Time:
- 2016-04-12 16:54:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 927066 | Davita Healthcare Partners Inc. | DVA | Services-Misc Health & Allied Services, Nec (8090) | 510354549 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1415548 | Javier Rodriguez | C/O Davita Healthcare Partners Inc. 2000 16Th Street Denver CO 80202 | Ceo-Kidney Care | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-04-11 | 216,667 | $43.35 | 317,397 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-04-11 | 126,755 | $74.10 | 190,642 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2016-04-11 | 89,912 | $73.51 | 100,730 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2016-04-11 | 216,667 | $0.00 | 216,667 | $43.35 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-04-13 | 2016-04-13 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2015.
- Represents the weighted average sale price of $73.5063. The range of prices for the sale of these shares was $73.24-$74.29, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The Stock Appreciation Rights were granted on 4/13/2011. 50% vested on 4/13/2014 and the remaining 50% vested on 4/13/2015.
Billionaire Hedge Funds
